Arcellx Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
62.02
1.33
(2.19%)
Volume:
833,016
52 week range:
47.88 - 107.37
Market Cap:
3.408B
Company Description:
Arcellx, Inc. engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM) It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent SparX proteins.